4.6 Article

Absence of CXCL10 Aggravates Herpes Stromal Keratitis with Reduced Primary Neutrophil Influx in Mice

期刊

JOURNAL OF VIROLOGY
卷 87, 期 15, 页码 8502-8510

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01198-13

关键词

-

类别

资金

  1. National Science Council in Taiwan [NSC-100-2320-B-006-014]

向作者/读者索取更多资源

Herpes simplex virus 1 (HSV-1) replication initiates inflammation and angiogenesis responses in the cornea to result in herpetic stromal keratitis (HSK), which is a leading cause of infection-induced vision impairment. Chemokines are secreted to modulate HSK by recruiting leukocytes, which affect virus growth, and by influencing angiogenesis. The present study used a murine infection model to investigate the significance of the chemokine CXC chemokine ligand 10 (CXCL10; gamma interferon-inducible protein 10 [IP-10]) in HSK. Here, we show that HSV-1 infection of the cornea induced CXCL10 protein expression in epithelial cells. The corneas of mice with a targeted disruption of the gene encoding CXCL10 displayed decreases in levels of neutrophil-attracting cytokine (interleukin-6), primary neutrophil influx, and viral clearance 2 or 3 days postinfection. Subsequently, absence of CXCL10 aggravated HSK with elevated levels of interleukin-6, chemokines for CD4(+)T cells and/or neutrophils (macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-2), angiogenic factor (vascular endothelial growth factor A), and secondary neutrophil influx, as well as infiltration of CD4(+)T cells to exacerbate opacity and angiogenesis in the cornea at 14 and up to 28 days postinfection. Our results collectively show that endogenous CXCL10 contributes to recruit the primary neutrophil influx and to affect the expression of cytokines, chemokines, and angiogenic factors as well as to reduce the viral titer and HSK severity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy

Yen-Chung Lai, Yung-Chun Chuang, Chih-Peng Chang, Yee-Shin Lin, Guey-Chuen Perng, Han-Chung Wu, Shie-Liang Hsieh, Trai-Ming Yeh

ANTIVIRAL RESEARCH (2018)

Article Critical Care Medicine

MACROPHAGE MIGRATION INHIBITORY FACTOR-INDUCED AUTOPHAGY CONTRIBUTES TO THROMBIN-TRIGGERED ENDOTHELIAL HYPERPERMEABILITY IN SEPSIS

Chiao-Hsuan Chao, Hong-Ru Chen, Yung-Chun Chuang, Trai-Ming Yeh

Article Infectious Diseases

Inhibition of autophagy protects against sepsis by concurrently attenuating the cytokine storm and vascular leakage

Liang-Hsuan Lu, Chiao-Hsuan Chao, Trai-Ming Yeh

JOURNAL OF INFECTION (2019)

Article Microbiology

Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage

Chiao-Hsuan Chao, Wei-Chueh Wu, Yen-Chung Lai, Pei-Jane Tsai, Guey-Chuen Perng, Yee-Shin Lin, Trai-Ming Yeh

PLOS PATHOGENS (2019)

Article Immunology

Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection

Yu-San Kao, Chia-Yi Yu, Hong-Jyun Huang, Sen-Mao Tien, Wan-Yu Wang, Martyr Yang, Robert Anderson, Trai-Ming Yeh, Yee-Shin Lin, Shu-Wen Wan

JOURNAL OF IMMUNOLOGY (2019)

Article Medicine, Research & Experimental

Regulation of autophagy, glucose uptake, and glycolysis under dengue virus infection

Ying-Ray Lee, Shan-Ying Wu, Ruei-Yi Chen, Yee-Shin Lin, Trai-Ming Yeh, Hsiao-Sheng Liu

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1

Zi-Yi Lu, Miao-Huei Cheng, Chia-Yi Yu, Yee-Shin Lin, Trai-Ming Yeh, Chia-Ling Chen, Chien-Chin Chen, Shu-Wen Wan, Chih-Peng Chang

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Immunology

A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein

Hong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, Shuying Wang, Chih-Peng Chang, Tzong-Shiann Ho, Yu-San Kao, Sen-Mao Tien, Hsing-Han Lin, Po-Chun Chang, Yen-Chung Lai, Yu-Peng Hsiao, Yi-Ling Liu, Chiao-Hsuan Chao, Robert Anderson, Trai-Ming Yeh, Yee-Shin Lin, Shu-Wen Wan

Summary: This study developed a modified DENV vaccine candidate with enhanced features by combining modifications of two DENV proteins. The vaccine candidate showed protective effects against DENV infection in a mouse model, indicating its potential clinical application.

VACCINE (2022)

Article Microbiology

Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model

Sen-Mao Tien, Po-Chun Chang, Yen-Chung Lai, Yung-Chun Chuang, Chin-Kai Tseng, Yu-San Kao, Hong-Jyun Huang, Yu-Peng Hsiao, Yi-Ling Liu, Hsing-Han Lin, Chien-Chou Chu, Miao-Huei Cheng, Tzong-Shiann Ho, Chih-Peng Chang, Shu-Fen Ko, Che-Piao Shen, Robert Anderson, Yee-Shin Lin, Shu-Wen Wan, Trai-Ming Yeh

Summary: Dengue virus (DENV) is a global health problem without effective treatment. This study demonstrates the potential of humanized anti-NS1 monoclonal antibodies (mAbs) as a therapeutic tool for DENV infection. The humanized mAbs showed therapeutic benefits in reducing bleeding time and skin hemorrhage, and they also inhibited vascular permeability and enhanced cytolysis of DENV-infected cells.

PLOS PATHOGENS (2022)

Article Immunology

Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2

Yen-Chung Lai, Yu-Wei Cheng, Chiao-Hsuan Chao, Yu-Ying Chang, Chi-De Chen, Wei-Jiun Tsai, Shuying Wang, Yee-Shin Lin, Chih-Peng Chang, Woei-Jer Chuang, Li-Yin Chen, Ying-Ren Wang, Sui-Yuan Chang, Wenya Huang, Jen-Ren Wang, Chin-Kai Tseng, Chun-Kuang Lin, Yung-Chun Chuang, Trai-Ming Yeh

Summary: In COVID-19 patients, elevated levels of ACE2 antibodies were found to cross-react with S1-RBD antibodies, suggesting a potential mechanism of immune response induced by SARS-CoV-2 infection. This cross-reactivity highlights the complex interactions between the virus and the host immune system in COVID-19 pathogenesis.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis

Yi-Ling Cheng, Chiao-Hsuan Chao, Yen-Chung Lai, Kun-Han Hsieh, Jen-Ren Wang, Shu-Wen Wan, Hong-Jyun Huang, Yung-Chun Chuang, Woei-Jer Chuang, Trai-Ming Yeh

Summary: This study confirms the presence of antibodies related to SARS-CoV-2 in dengue virus patients, and these antibodies can cross-react with proteins of the dengue virus. These antibodies can inhibit the pathological reactions caused by dengue virus infection, potentially providing some level of protection against dengue virus.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan

Chiao-Hsuan Chao, Dayna Cheng, Sheng-Wen Huang, Yung-Chun Chuang, Trai-Ming Yeh, Jen-Ren Wang

Summary: This study collected serum samples from 113 Taiwan participants after receiving different SARS-CoV-2 vaccines and compared the differences in immune responses. The results showed that mRNA vaccines elicited higher levels of antibodies and had higher broadly neutralizing ability compared to AZD1222. Additionally, the study found a significant increase in anti-ACE2 autoantibodies after vaccination.

FRONTIERS IN IMMUNOLOGY (2022)

Meeting Abstract Immunology

Development of dengue virus vaccine by targeting at nonstructural protein 1 wing domain

T. M. Yeh

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Review Cell Biology

Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate

Hong-Ru Chen, Yen-Chung Lai, Trai-Ming Yeh

JOURNAL OF BIOMEDICAL SCIENCE (2018)

暂无数据